X

MRNA

Moderna (MRNA) set to take advantage of opportunity in vaccines

Shares of Moderna Inc. (NASDAQ: MRNA) have gained 246% since the beginning of this year and more than 279% over…

Moderna, Inc. (MRNA) Q2 2020 Earnings Conference Call Transcript

Moderna Inc. (NASDAQ: MRNA) Q2 2020 earnings call dated Aug. 05, 2020 Corporate Participants: Lavina Talukdar — Head of Investor Relations Stephane…

Moderna Inc  (NASDAQ: MRNA) Moderna Vaccine Against COVID-19 Phase 1 Interim Results Publication Call Transcript

Moderna Inc  (NASDAQ: MRNA) Moderna Vaccine Against COVID-19 Phase 1 Interim Results Publication Call dated July 15, 2020 Corporate Participants:…

Moderna Inc (NASDAQ: MRNA) Q1 2020 Earnings Call Transcript

Moderna Inc (MRNA) Q1 2020 earnings call dated May 07, 2020 Corporate Participants: Lavina Talukdar — Head of Investor Relations Stephane Bancel — Chief…

Moderna (NASDAQ: MRNA) SARS-CoV-2 Vaccine Interim Phase 1 Data Call Transcript

Moderna Inc (MRNA) Q1 2019 interim phase 1 data conference call dated May. 18, 2020 Corporate Participants: Lavina Talukdar — Head of…

Moderna (MRNA) soars to a new 52-week high on positive phase 1 COVID-19 vaccine data

The entire world is waiting for some good news on a vaccine for the novel coronavirus. So far the global…

Moderna (MRNA) ships coronavirus vaccine candidate for trials, shares hit a peak

Shares of Moderna Inc. (NASDAQ: MRNA) soared to a record high of $29.98 on Wednesday after shipping the first coronavirus…